Buyer for clinical research organization in Europe

Company to buy

• Size: Mid-sized business
• Revenue: 2 – 20 million EUR
• Location of the target company: Europe
• CFIE PHB273

Overview of buyer for clinical research organization in Europe

This technology-driven clinical research organization is advancing precision medicine. Primarily, the company facilitates this by giving patients access to investigational treatments, regardless of treatment location. Critically, the company connects physicians, research sites, and clinical trial sponsors worldwide through its integrated platform. As a result, this enables efficient and meaningful patient matching for clinical trials and compassionate use programs. Notably, this approach transforms the clinical development landscape by making studies readily accessible to treating physicians across various therapeutic areas.

Profile of buyer for clinical research organization in Europe

Chiefly, the company operates a comprehensive clinical research organization. In particular, the platform serves as a bridge. Crucially, it unites global clinical research resources with treating physicians. Consequently, these doctors can rapidly pair patients with relevant studies. Foremost, its primary mission is to accelerate access to new treatments, especially in complex fields. For instance, in oncology, infectious diseases, neurology, immunology, cardiology, and rare diseases. Above all, the aim is to simplify and speed up clinical trials at reduced costs.

Activity and products of buyer for clinical research organization in Europe

Overall, the company offers an innovative technology platform that provides comprehensive support for the clinical development process. This platform includes numerous features such as a global sponsor and study registry, patient-matching technology, site, and physician qualification. In addition, rapid study activation, real-time data capture, and evidence generation are equally important. Further, this system enables direct access to key decision-makers within manufacturers and simplifies study feasibility and patient enrollment. Moreover, it ensures seamless regulatory compliance. Above all, it is designed to streamline clinical trials, from study feasibility to data collection, providing an end-to-end solution for sponsors and research sites.

Highlights of buyer for clinical research organization in Europe

• Connects thousands of sponsors, research sites, and investigators, facilitating physicians to directly access and engage in clinical trials and compassionate use programs.
• Matches patients efficiently with relevant clinical trials based on study criteria, site capabilities, and patient clinical characteristics.
• Activates research sites within 5 working days using a standardized master contract and fee schedule, enabling quicker patient enrollment and access.
• Integrates data capture and evidence generation to support product development across various therapeutic indications.
• Provides just-in-time connections with key decision-makers, accelerating the availability of investigational products and new treatments for patients globally.

More information on this buyer for clinical research organization in Europe

Please get in touch if you are interested in learning more about this buyer for clinical research organization in Europe. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.